105 related articles for article (PubMed ID: 11716514)
1. Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors.
Wang EJ; Casciano CN; Clement RP; Johnson WW
Biochem Biophys Res Commun; 2001 Nov; 289(2):580-5. PubMed ID: 11716514
[TBL] [Abstract][Full Text] [Related]
2. P-Glycoprotein (P-gp) expressed in a confluent monolayer of hMDR1-MDCKII cells has more than one efflux pathway with cooperative binding sites.
Acharya P; Tran TT; Polli JW; Ayrton A; Ellens H; Bentz J
Biochemistry; 2006 Dec; 45(51):15505-19. PubMed ID: 17176072
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol interaction with the daunorubicin binding site of P-glycoprotein.
Wang E; Casciano CN; Clement RP; Johnson WW
Biochem Biophys Res Commun; 2000 Oct; 276(3):909-16. PubMed ID: 11027568
[TBL] [Abstract][Full Text] [Related]
4. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
Taub ME; Podila L; Ely D; Almeida I
Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
[TBL] [Abstract][Full Text] [Related]
5. Cooperativity in the inhibition of P-glycoprotein-mediated daunorubicin transport: evidence for half-of-the-sites reactivity.
Wang EJ; Casciano CN; Clement RP; Johnson WW
Arch Biochem Biophys; 2000 Nov; 383(1):91-8. PubMed ID: 11097180
[TBL] [Abstract][Full Text] [Related]
6. Bivalent probes of the human multidrug transporter P-glycoprotein.
Pires MM; Hrycyna CA; Chmielewski J
Biochemistry; 2006 Sep; 45(38):11695-702. PubMed ID: 16981729
[TBL] [Abstract][Full Text] [Related]
7. Kinetic identification of membrane transporters that assist P-glycoprotein-mediated transport of digoxin and loperamide through a confluent monolayer of MDCKII-hMDR1 cells.
Acharya P; O'Connor MP; Polli JW; Ayrton A; Ellens H; Bentz J
Drug Metab Dispos; 2008 Feb; 36(2):452-60. PubMed ID: 17967933
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.
Meredith JE; Thompson LA; Toyn JH; Marcin L; Barten DM; Marcinkeviciene J; Kopcho L; Kim Y; Lin A; Guss V; Burton C; Iben L; Polson C; Cantone J; Ford M; Drexler D; Fiedler T; Lentz KA; Grace JE; Kolb J; Corsa J; Pierdomenico M; Jones K; Olson RE; Macor JE; Albright CF
J Pharmacol Exp Ther; 2008 Aug; 326(2):502-13. PubMed ID: 18499745
[TBL] [Abstract][Full Text] [Related]
9. Human pharmaceuticals modulate P-gp1 (ABCB1) transport activity in the fish cell line PLHC-1.
Caminada D; Zaja R; Smital T; Fent K
Aquat Toxicol; 2008 Nov; 90(3):214-22. PubMed ID: 18950875
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of the activity of P-glycoprotein by a semi-automated fluorometric method.
Spengler G; Viveiros M; Martins M; Rodrigues L; Martins A; Molnar J; Couto I; Amaral L
Anticancer Res; 2009 Jun; 29(6):2173-7. PubMed ID: 19528478
[TBL] [Abstract][Full Text] [Related]
11. Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp.
Molnár J; Kars MD; Gündüz U; Engi H; Schumacher U; Van Damme EJ; Peumans WJ; Makovitzky J; Gyémánt N; Molnár P
Acta Histochem; 2009; 111(4):329-33. PubMed ID: 19124148
[TBL] [Abstract][Full Text] [Related]
12. Measurement of basal, substrate induced and total P-glycoprotein activity in bronchoalveolar lavage T-cell subsets.
Donnenberg VS; Wilson JW; Burckart GJ; Zeevi A; Iacono A; Donnenberg AD
Cytometry A; 2004 Feb; 57(2):75-85. PubMed ID: 14750128
[TBL] [Abstract][Full Text] [Related]
13. Regional differences in capillary density, perfusion rate, and P-glycoprotein activity: a quantitative analysis of regional drug exposure in the brain.
Zhao R; Pollack GM
Biochem Pharmacol; 2009 Oct; 78(8):1052-9. PubMed ID: 19523457
[TBL] [Abstract][Full Text] [Related]
14. Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites.
Wang EJ; Casciano CN; Clement RP; Johnson WW
Pharm Res; 2003 Apr; 20(4):537-44. PubMed ID: 12739759
[TBL] [Abstract][Full Text] [Related]
15. A continuous fluorescence assay for the study of P-glycoprotein-mediated drug efflux using inside-out membrane vesicles.
Bebawy M; Morris MB; Roufogalis BD
Anal Biochem; 1999 Mar; 268(2):270-7. PubMed ID: 10075817
[TBL] [Abstract][Full Text] [Related]
16. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 3 assay systems using a common probe substrate, calcein AM, for studying P-gp using a selected set of compounds.
Szerémy P; Pál A; Méhn D; Tóth B; Fülöp F; Krajcsi P; Herédi-Szabó K
J Biomol Screen; 2011 Jan; 16(1):112-9. PubMed ID: 21057029
[TBL] [Abstract][Full Text] [Related]
18. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.
Zhu HJ; Wang JS; Markowitz JS; Donovan JL; Gibson BB; Gefroh HA; Devane CL
J Pharmacol Exp Ther; 2006 May; 317(2):850-7. PubMed ID: 16439618
[TBL] [Abstract][Full Text] [Related]
19. In vitro p-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates.
Rautio J; Humphreys JE; Webster LO; Balakrishnan A; Keogh JP; Kunta JR; Serabjit-Singh CJ; Polli JW
Drug Metab Dispos; 2006 May; 34(5):786-92. PubMed ID: 16455806
[TBL] [Abstract][Full Text] [Related]
20. Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery.
Schwab D; Fischer H; Tabatabaei A; Poli S; Huwyler J
J Med Chem; 2003 Apr; 46(9):1716-25. PubMed ID: 12699389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
